S

Stereotaxis Inc
AMEX:STXS

Watchlist Manager
Stereotaxis Inc
AMEX:STXS
Watchlist
Price: 1.94 USD Market Closed
Market Cap: 164.2m USD
Have any thoughts about
Stereotaxis Inc?
Write Note

Intrinsic Value

The intrinsic value of one STXS stock under the Base Case scenario is 1.4 USD. Compared to the current market price of 1.94 USD, Stereotaxis Inc is Overvalued by 28%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

STXS Intrinsic Value
1.4 USD
Overvaluation 28%
Intrinsic Value
Price
S
Base Case Scenario

Valuation Backtest
Stereotaxis Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for STXS cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about STXS?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Stereotaxis Inc

Provide an overview of the primary business activities
of Stereotaxis Inc.

What unique competitive advantages
does Stereotaxis Inc hold over its rivals?

What risks and challenges
does Stereotaxis Inc face in the near future?

Has there been any significant insider trading activity
in Stereotaxis Inc recently?

Summarize the latest earnings call
of Stereotaxis Inc.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Stereotaxis Inc.

Provide P/S
for Stereotaxis Inc.

Provide P/E
for Stereotaxis Inc.

Provide P/OCF
for Stereotaxis Inc.

Provide P/FCFE
for Stereotaxis Inc.

Provide P/B
for Stereotaxis Inc.

Provide EV/S
for Stereotaxis Inc.

Provide EV/GP
for Stereotaxis Inc.

Provide EV/EBITDA
for Stereotaxis Inc.

Provide EV/EBIT
for Stereotaxis Inc.

Provide EV/OCF
for Stereotaxis Inc.

Provide EV/FCFF
for Stereotaxis Inc.

Provide EV/IC
for Stereotaxis Inc.

Show me price targets
for Stereotaxis Inc made by professional analysts.

What are the Revenue projections
for Stereotaxis Inc?

How accurate were the past Revenue estimates
for Stereotaxis Inc?

What are the Net Income projections
for Stereotaxis Inc?

How accurate were the past Net Income estimates
for Stereotaxis Inc?

What are the EPS projections
for Stereotaxis Inc?

How accurate were the past EPS estimates
for Stereotaxis Inc?

What are the EBIT projections
for Stereotaxis Inc?

How accurate were the past EBIT estimates
for Stereotaxis Inc?

Compare the revenue forecasts
for Stereotaxis Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Stereotaxis Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Stereotaxis Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Stereotaxis Inc compared to its peers.

Compare the P/E ratios
of Stereotaxis Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Stereotaxis Inc with its peers.

Analyze the financial leverage
of Stereotaxis Inc compared to its main competitors.

Show all profitability ratios
for Stereotaxis Inc.

Provide ROE
for Stereotaxis Inc.

Provide ROA
for Stereotaxis Inc.

Provide ROIC
for Stereotaxis Inc.

Provide ROCE
for Stereotaxis Inc.

Provide Gross Margin
for Stereotaxis Inc.

Provide Operating Margin
for Stereotaxis Inc.

Provide Net Margin
for Stereotaxis Inc.

Provide FCF Margin
for Stereotaxis Inc.

Show all solvency ratios
for Stereotaxis Inc.

Provide D/E Ratio
for Stereotaxis Inc.

Provide D/A Ratio
for Stereotaxis Inc.

Provide Interest Coverage Ratio
for Stereotaxis Inc.

Provide Altman Z-Score Ratio
for Stereotaxis Inc.

Provide Quick Ratio
for Stereotaxis Inc.

Provide Current Ratio
for Stereotaxis Inc.

Provide Cash Ratio
for Stereotaxis Inc.

What is the historical Revenue growth
over the last 5 years for Stereotaxis Inc?

What is the historical Net Income growth
over the last 5 years for Stereotaxis Inc?

What is the current Free Cash Flow
of Stereotaxis Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Stereotaxis Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Stereotaxis Inc

Current Assets 28.1m
Cash & Short-Term Investments 14.7m
Receivables 2.8m
Other Current Assets 10.6m
Non-Current Assets 7.9m
PP&E 7.8m
Other Non-Current Assets 116k
Current Liabilities 12.3m
Accounts Payable 4.1m
Accrued Liabilities 2.1m
Other Current Liabilities 6m
Non-Current Liabilities 7m
Other Non-Current Liabilities 7m
Efficiency

Earnings Waterfall
Stereotaxis Inc

Revenue
23.7m USD
Cost of Revenue
-9.7m USD
Gross Profit
14.1m USD
Operating Expenses
-35.8m USD
Operating Income
-21.7m USD
Other Expenses
-374k USD
Net Income
-22.1m USD

Free Cash Flow Analysis
Stereotaxis Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Earnings Calls

In the second quarter of 2024, Stereotaxis reported revenue of $4.5 million, a decline from $7.9 million last year, primarily due to delays in system deliveries. The backlog stood at $15.3 million, and the gross margin was 74%. Looking forward, the company anticipates over $14 million in revenue for the second half of the year. It aims to consolidate results from its recent APT acquisition from August. The anticipated launch of GenesisX and a proprietary catheter, MAGiC, are expected to significantly improve revenue per procedure, enhancing Stereotaxis's growth outlook.

What is Earnings Call?
Fundamental Scores

STXS Profitability Score
Profitability Due Diligence

Stereotaxis Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
Negative 1-Year Revenue Growth
Negative 3-Years Revenue Growth
19/100
Profitability
Score

Stereotaxis Inc's profitability score is 19/100. The higher the profitability score, the more profitable the company is.

STXS Solvency Score
Solvency Due Diligence

Stereotaxis Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Long-Term Solvency
Low Altman Z-Score
52/100
Solvency
Score

Stereotaxis Inc's solvency score is 52/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

STXS Price Targets Summary
Stereotaxis Inc

Wall Street analysts forecast STXS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for STXS is 4.59 USD with a low forecast of 4.04 USD and a high forecast of 5.25 USD.

Lowest
Price Target
4.04 USD
108% Upside
Average
Price Target
4.59 USD
137% Upside
Highest
Price Target
5.25 USD
171% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for STXS?

Click here to dive deeper.

Dividends

Stereotaxis Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for STXS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

STXS Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Stereotaxis Inc

Country

United States of America

Industry

Health Care

Market Cap

161m USD

Dividend Yield

0%

Description

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. The company is headquartered in St. Louis, Missouri and currently employs 130 full-time employees. The company went IPO on 2004-08-12. The firm's robotic technology, Robotic Magnetic Navigation, fundamentally transforms endovascular interventions using computer-controlled magnetic fields to directly control the tip of flexible interventional catheters or devices. Its primary products include the Genesis RMN System, the Odyssey Solution, and other related devices. The firm also offers to its customers the Stereotaxis Imaging Model S X-ray System and other accessory devices. The Genesis RMN System is designed to enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites. The Odyssey Solution consolidates lab information onto an integrated display, enabling physicians to view and control all the key information in the operating room.

Contact

MISSOURI
St. Louis
710 N Tucker Blvd, Ste 110
+13146786100.0
www.stereotaxis.com

IPO

2004-08-12

Employees

130

Officers

CEO & Chairman
Dr. David Leo Fischel C.A.I.A., C.F.A., C.P.A., M.B.A.
CFO & Secretary
Ms. Kimberly R. Peery
Vice President of Operations
Mr. Keith Galloway

See Also

Discover More
What is the Intrinsic Value of one STXS stock?

The intrinsic value of one STXS stock under the Base Case scenario is 1.4 USD.

Is STXS stock undervalued or overvalued?

Compared to the current market price of 1.94 USD, Stereotaxis Inc is Overvalued by 28%.

Back to Top